The Traumatic Brain Injury Therapeutics Market is estimated to be valued at US$ 3.46 Billion In 2022 and is expected to exhibit a CAGR of 6.20% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Traumatic Brain Injury Therapeutics Market refers to the pharmaceutical products and therapies used in the treatment of traumatic...
Traumatic brain injury (TBI) occurs due to a blow or jolt to the head that disrupts the normal functioning of the brain. Common causes include falls, vehicle accidents, sports injuries, and violent attacks. Mild TBI can cause headaches, dizziness, fatigue and memory problems while severe TBI leads to damage of brain tissues and functions controlled by that tissue. Therapeutics to treat TBI aim...
The Traumatic Brain Injury Therapeutics Market has been experiencing significant growth in recent years, driven by an increased understanding of TBI pathophysiology, rising incidence of brain injuries due to accidents and sports-related activities, and advancements in medical technology. TBI refers to severe injuries to the brain caused by external physical force, leading to cognitive, motor,...